The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVIDKelly Sealey
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
National COVID-19 trends, September 1National COVID-19 trends, September 1Betsy Ladyzhets
Research updates, September 1Research updates, September 1Miles W. Griffis

Policy & Advocacy

  • March 18, 2024

    Photo essay: Long Covid advocates gather in DC for demonstration

  • March 15, 2024

    Sen. Bernie Sanders introduces resolution to formalize Long Covid Awareness Day

  • March 12, 2024

    How mask blocs are keeping communities safe with neglected government stockpiles

  • abraham lincoln statue
    March 5, 2024

    It’s “all hands on deck” for Long Covid Awareness Day as the CDC ignores Long Covid in new guidance

  • February 27, 2024

    Q&A: Dr. Ian Simon on his plans for the HHS Office of Long Covid Research and Practice

  • January 30, 2024

    A win for healthcare workers and patients: The CDC returns HICPAC’s draft recommendations on infection control

Previous Page
1 … 13 14 15 16 17 18
Next Page

Science

  • A bright collage of orange, turquoise, and terracotta that includes captivating, pink hollyhock flowers, a person with long hair in a high quality mask, ristras (red, dried chili peppers) and a black and white poster for the keystone symposia for Long COVID and other post-acute infection syndromes.
    August 19, 2025

    “The field is coming of age”: Long COVID researchers gather in Santa Fe to foster collaboration

  • A microscopic computer illustration of the aspergillus fungus. It appears like a protea flower mixed with an anenome, made up of bright red, yellow, and green "flowers" with red stems. It is very psychadelic and captivating.
    August 19, 2025

    Research updates, August 19

  • Collage graphic showing a monoclonal antibody infusion in progress (in blue) on the left and a pile of antiviral pills (in orange) on the right. Behind these images, there's a background showing a microscope image of SARS-CoV-2.
    August 12, 2025

    No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential

  • A photo of colorful Lego-like pieces making up a DNA double helix.
    August 12, 2025

    Research updates, August 12

  • Graphic showing vials of three JAK inhibitor drugs: Rinvoq, Cibinqo, Olumiant. The vials are shown with colorful echoes and the graphic has a black and white dotted background, creating a trippy vibe.
    August 5, 2025

    Three clinical trials for Long COVID are testing JAK inhibitors to treat immune dysregulation

  • A cute white mouse perches on the side of a plastic bowl on a metal table in a research lab. The mouse has pink ears, nose, feet, and a long tail.
    August 5, 2025

    Research updates, August 5

Previous Page
1 … 13 14 15 16 17 … 38
Next Page

Covid-19

  • A set of four charts, titled "Regional Wastewater Concentrations." All four are line charts showing data from November 2023 through March 2025, with colored lines representing the four U.S. regions: yellow for Northeast, purple for Midwest, green for West, pink for South. The influenza A, influenza B, and RSV charts show clear waves over winter 2023-24 and 2024-25; the COVID-19 chart also shows a summer 2024 wave.
    March 25, 2025

    National COVID-19 trends, March 25

  • Line chart titled, "SARS-CoV-2, All Wastewater Sites." The chart shows the national average of coronavirus readings in wastewater from across the U.S., representing sites in WWSCAN's network. The Y axis represents quantity of nucleic acids (PPMoV Normalized, x1 million) and the Y axis represents time, going from October 2023 to March 2025. It shows a major wave in winter 2023-24, a smaller wave in summer 2024, and then another smaller but longer wave in winter 2024-25, now plateaued at a moderate level.
    March 18, 2025

    National COVID-19 trends, March 18

  • Chart titled, "Americans' Return to Pre-Pandemic Normalcy." Text at the top reads: "Thinking about your life before the start of the coronavirus, would you say your life right now is completely back to normal, somewhat back to normal but not completely normal, or not yet back to normal? If not back to normal: Do you think your life will ever get completely back to the “normal” that existed before the coronavirus pandemic?" The green line representing "completely back to normal" is at 47% in the most recent poll results; the dark blue line representing "no, but will get back" is at 13%; and the light blue line representing "no, will never get back to normal" is at 40%.
    March 11, 2025

    National COVID-19 trends, March 11

  • Line chart titled, "National SARS-CoV-2 Wastewater Concentrations." The Y axis is "effective concentration, copies/mL" and the X axis is time, going from March 2020 to March 2025. The chart shows COVID-19's many waves in the U.S. over the last five years; the most recent weeks of data show a smaller winter peak followed by a high plateau.
    March 4, 2025

    National COVID-19 trends, March 4

  • State-by-state map of the U.S., with states color-coded according to "Respiratory illness activity." Green represents low, orange is moderate, red is high, purple is very high, and gray is data unavailable. Most states across the U.S. are in the moderate or high category, with a few at very high (Wisconsin, Ohio, Pennsylvania, West Virginia, Maryland, Delaware, New Hampshire, Kansas, Oklahoma) and low (Alabama, North Dakota, New Mexico, Nevada). Text at the bottom of the map reads: "Data last updated on February 19, 2025 and presented through February 15, 2025. View this dataset on data.cdc.gov."
    February 25, 2025

    National COVID-19 trends, February 25

  • February 21, 2025

    Trump commands HHS to terminate advisory committee on Long COVID 

Previous Page
1 … 13 14 15 16 17 … 31
Next Page

Health

  • This graphic has the background of an envelope with a map of the world overlaid. On red icons in the shape of the coronavirus, there are small images of an airplane, a bottle of pills, and a person wearing a respirator.
    December 12, 2024

    With no approved treatments and little support, people with Long COVID turn to online drug markets

  • Graphic shows a hand banging a gavel, with a red burst coming out of the base and a text bubble with asterisks and exclamation points.
    December 3, 2024

    We talked to a veteran lawyer about applying for disability insurance with Long COVID and ME

  • This graphic shows a golden staircase leading up to an uncertain location. The walls and sides of the image are in pink and other pastel colors.
    November 11, 2024

    The trouble with recovery stories

  • October 18, 2024

    Solange Knowles thanks chronic illness community, shares POTS, MCAS, and Sjögren’s diagnoses

  • Three researchers stand in a health clinic's waiting area, in between armchairs and a piano. Amy Proal on the left has blonde hair and wears a floral shirt; David Putrino in the middle wears a blue shirt and slacks; Joseph Herrera on the right wears a navy suit. All three wear KN95 masks.
    October 15, 2024

    New Long COVID and complex disease center at Mount Sinai set to be a leader in research, clinical care

  • October 14, 2024

    Filmmaker Jesse Ridgway shares experience with Long COVID with millions of followers

Previous Page
1 … 13 14 15 16 17 … 20
Next Page

Commentary

  • November 14, 2023

    Welcome to The Sick Times, a letter from our co-founder, Betsy Ladyzhets

  • woman in beige coat standing near white wooden book shelf
    November 14, 2023

    We want to hear from you! Take our reader survey

Previous Page
1 … 25 26 27

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...